SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Dwight D. Eisenhower Synthetic CCD

PatientDwight D. Eisenhower
Date of birth1960-10-14
IdentifiersMRN HR-ET015-SYN; SSN (made up) 000-15-2673
Document date2026-11-01
AuthorRussell Okonkwo, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Reason for Visit

Primary care visit to establish care after myocardial infarction and plan a return to full-time work. Concerns: Wants to return to a demanding full-time job and travel without bringing on another heart attack; Worries that limits on work, golf, and travel will be permanent. [S]

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Medications

MedicationFrequencyRouteDatesStatusEvidence
Aspirin 81 mg delayed-release oral tablet, one tablet by mouth dailyOne tablet by mouth dailyOral route2025-09-24activeS
Ticagrelor 90 mg oral tablet, one tablet by mouth twice dailyOne tablet by mouth twice dailyOral route2025-09-24 to 2026-09-28completedS
Atorvastatin 80 mg oral tablet, one tablet by mouth dailyOne tablet by mouth dailyOral route2025-09-24activeS
Metoprolol succinate 25 mg extended-release oral tablet, one tablet by mouth dailyOne tablet by mouth dailyOral route2025-09-25activeS
Lisinopril 5 mg oral tablet, one tablet by mouth dailyOne tablet by mouth dailyOral route2025-09-26 to 2026-01-12completedS
Lisinopril 10 mg oral tablet, one tablet by mouth dailyOne tablet by mouth dailyOral route2026-01-12activeS
Ezetimibe 10 mg oral tablet, one tablet by mouth dailyOne tablet by mouth dailyOral route2026-01-12activeS
Nitroglycerin 0.4 mg sublingual tablet, one tablet under the tongue every 5 minutes as needed for chest pain, up to 3 tablets; call 911 if pain is not better 5 minutes after the first tabletOne tablet under the tongue every 5 minutes as needed for chest pain, up to 3 dosesSublingual route2025-09-24activeS

Procedures

ProcedureDatesStatusEvidence
Coronary angiography and percutaneous coronary intervention: occluded proximal left anterior descending artery treated with one drug-eluting stent; no other significant stenosis. Performed at an out-of-state hospital after a late presentation with continuing chest pain2025-09-24 to 2025-09-24completedS
Transthoracic echocardiography in the hospital: ejection fraction 45 percent with anterior and apical hypokinesis, no thrombus2025-09-25 to 2025-09-25completedS
Outpatient cardiac rehabilitation, phase 2: 36 sessions completed; exit exercise test 9 METs without angina, ischemic ECG changes, or arrhythmia2025-10-13 to 2026-01-09completedS
12-lead electrocardiogram: sinus rhythm 62/min, Q waves in V1 to V3 from the old anterior infarction, no acute ST change2026-01-12 to 2026-01-12completedS
Transthoracic echocardiography: ejection fraction 52 percent, mild apical hypokinesis, no thrombus or aneurysm, normal valves2026-01-26 to 2026-01-26completedS

Immunizations

DateVaccineStatusEvidence
2025-10-20High-dose influenza vaccine, 2025-2026 seasoncompletedS
2026-01-12Pneumococcal conjugate vaccine PCV20completedS
2023-03-06Recombinant zoster vaccine, two-dose series completedcompletedS
2019-08-12Tdap vaccinecompletedS
2026-09-28Respiratory syncytial virus vaccine, single dosecompletedS
2026-10-19High-dose influenza vaccine, 2026-2027 seasoncompletedS

Past Medical History

Historical biography with true dates. These events are not part of the synthetic care timeline.

Historical dateHistoryEvidence
September 24, 1955Heart attack in Denver after a day of golf: anterolateral myocardial infarction with ST elevation, hospitalized more than 24 hours after symptoms began, then seven weeks at Fitzsimons Army HospitalD (CLM-0003, CLM-0004, CLM-0005)
about 1949Heavy cigarette smoking, about four packs a day during the war years; quit around 1949 at a doctor's suggestionD (CLM-0002)

Family History

No family medical history is documented in the logged sources. Family history of real relatives is recorded only from documented or retrospective sources and is never synthesized.

Health Concerns

ConcernStatusEvidence
Wants to return to a demanding full-time job and travel without bringing on another heart attackactiveS
Worries that limits on work, golf, and travel will be permanentactiveS

Assessment

Most recent measures: Cholesterol [Mass/volume] in Serum or Plasma 116 on 2026-09-28; Cholesterol in HDL [Mass/volume] in Serum or Plasma 45 on 2026-09-28; Triglyceride [Mass/volume] in Serum or Plasma 110 on 2026-09-28; Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation 49 on 2026-09-28; Lipoprotein a [Mass/volume] in Serum or Plasma 22 on 2026-01-12; Sodium [Moles/volume] in Serum or Plasma 140 on 2026-09-28; Potassium [Moles/volume] in Serum or Plasma 4.5 on 2026-09-28; Creatinine [Mass/volume] in Serum or Plasma 1.02 on 2026-09-28; Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M 82 on 2026-09-28; Glucose [Mass/volume] in Serum or Plasma 95 on 2026-09-28; Hemoglobin [Mass/volume] in Blood 14.3 on 2026-04-13; Platelets [#/volume] in Blood by Automated count 221 on 2026-04-13; Hemoglobin A1c/Hemoglobin.total in Blood 5.6 on 2026-01-12; Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 26 on 2026-03-16; Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 0 on 2026-10-19; Total score [AUDIT-C] 1 on 2026-10-19; Left ventricular Ejection fraction 52 on 2026-01-26; Total score [Mini-Cog] 5 on 2026-10-19 [S]

Strengths and supports: Married; lives with his spouse; supportive family and close working staff [S]

Problems

ProblemClinical statusVerificationCodeProvenance
Anterior ST-elevation myocardial infarction about four months before intake, treated with a drug-eluting stent to the left anterior descending artery; synthetic modern episode linked to the documented 1955 anterolateral infarctionactiveconfirmed I25.2S — Synthetic modern diagnosis; the 1955 infarction remains D in the history.
Coronary artery disease, single-vessel, after stenting; no anginaactiveconfirmed I25.10S — Synthetic diagnosis supporting secondary prevention.
Hyperlipidemia, on high-intensity statinactiveconfirmed E78.5S — Synthetic diagnosis; no cholesterol value from his lifetime is used.
Essential hypertensionactiveconfirmed I10S — Synthetic diagnosis; no blood pressure from his lifetime is used.
Former heavy cigarette smoker, quit about seven years before intakeactiveconfirmed Z87.891S — Synthetic coded history echoing the documented heavy smoking and quitting around 1949.
Anterior epistaxis, right side, on dual antiplatelet therapy; controlled with silver nitrate cauteryresolvedconfirmed R04.0S — Synthetic intercurrent illness at an unscheduled visit; it does not echo a documented illness.

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-01-12Cholesterol [Mass/volume] in Serum or Plasma150mg/dL<=199 mg/dLNormalS
2026-01-12Cholesterol in HDL [Mass/volume] in Serum or Plasma42mg/dL>=40 mg/dLNormalS
2026-01-12Triglyceride [Mass/volume] in Serum or Plasma150mg/dL<=149 mg/dLHighS
2026-01-12Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation78mg/dL<=99 mg/dLNormalS
2026-01-12Lipoprotein a [Mass/volume] in Serum or Plasma22mg/dL<=29 mg/dLNormalS
2026-01-12Sodium [Moles/volume] in Serum or Plasma140mmol/L135-145 mmol/LNormalS
2026-01-12Potassium [Moles/volume] in Serum or Plasma4.4mmol/L3.5-5.1 mmol/LNormalS
2026-01-12Creatinine [Mass/volume] in Serum or Plasma1mg/dL0.74-1.35 mg/dLNormalS
2026-01-12Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M84mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
2026-01-12Glucose [Mass/volume] in Serum or Plasma96mg/dL70-99 mg/dLNormalS
2026-01-12Hemoglobin [Mass/volume] in Blood14.6g/dL13.2-16.6 g/dLNormalS
2026-01-12Platelets [#/volume] in Blood by Automated count22810*3/uL150-400 10*3/uLNormalS
2026-01-12Hemoglobin A1c/Hemoglobin.total in Blood5.6%<=5.6%NormalS
2026-01-12Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma24U/L7-56 U/LNormalS
2026-01-12Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]1{score}S
2026-01-12Total score [AUDIT-C]1{score}S
2026-01-26Sodium [Moles/volume] in Serum or Plasma139mmol/L135-145 mmol/LNormalS
2026-01-26Potassium [Moles/volume] in Serum or Plasma4.6mmol/L3.5-5.1 mmol/LNormalS
2026-01-26Creatinine [Mass/volume] in Serum or Plasma1.04mg/dL0.74-1.35 mg/dLNormalS
2026-01-26Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M80mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
2026-01-26Glucose [Mass/volume] in Serum or Plasma94mg/dL70-99 mg/dLNormalS
2026-01-26Left ventricular Ejection fraction52%50-70%NormalS
2026-03-16Cholesterol [Mass/volume] in Serum or Plasma118mg/dL<=199 mg/dLNormalS
2026-03-16Cholesterol in HDL [Mass/volume] in Serum or Plasma44mg/dL>=40 mg/dLNormalS
2026-03-16Triglyceride [Mass/volume] in Serum or Plasma120mg/dL<=149 mg/dLNormalS
2026-03-16Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation50mg/dL<=99 mg/dLNormalS
2026-03-16Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma26U/L7-56 U/LNormalS
2026-03-16Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]0{score}S
2026-05-11Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]0{score}S
2026-09-28Cholesterol [Mass/volume] in Serum or Plasma116mg/dL<=199 mg/dLNormalS
2026-09-28Cholesterol in HDL [Mass/volume] in Serum or Plasma45mg/dL>=40 mg/dLNormalS
2026-09-28Triglyceride [Mass/volume] in Serum or Plasma110mg/dL<=149 mg/dLNormalS
2026-09-28Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation49mg/dL<=99 mg/dLNormalS
2026-09-28Sodium [Moles/volume] in Serum or Plasma140mmol/L135-145 mmol/LNormalS
2026-09-28Potassium [Moles/volume] in Serum or Plasma4.5mmol/L3.5-5.1 mmol/LNormalS
2026-09-28Creatinine [Mass/volume] in Serum or Plasma1.02mg/dL0.74-1.35 mg/dLNormalS
2026-09-28Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M82mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
2026-09-28Glucose [Mass/volume] in Serum or Plasma95mg/dL70-99 mg/dLNormalS
2026-09-28Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]0{score}S
2026-04-13Hemoglobin [Mass/volume] in Blood14.3g/dL13.2-16.6 g/dLNormalS
2026-04-13Platelets [#/volume] in Blood by Automated count22110*3/uL150-400 10*3/uLNormalS
2026-10-19Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]0{score}S
2026-10-19Total score [Mini-Cog]5{score}S
2026-10-19Total score [AUDIT-C]1{score}S

Social History

Vital Signs

DateMeasureValueUnitProvenance
2026-01-12Body height178cmS
2026-01-12Body weight79kgS
2026-01-12Body mass index (BMI) [Ratio]24.9kg/m2S
2026-01-12Systolic blood pressure136mm[Hg]S
2026-01-12Diastolic blood pressure82mm[Hg]S
2026-01-12Heart rate62/minS
2026-01-12Respiratory rate14/minS
2026-01-12Body temperature36.6CelS
2026-01-12Oxygen saturation in Arterial blood by Pulse oximetry98%S
2026-01-26Body height178cmS
2026-01-26Body weight78.6kgS
2026-01-26Body mass index (BMI) [Ratio]24.8kg/m2S
2026-01-26Systolic blood pressure128mm[Hg]S
2026-01-26Diastolic blood pressure78mm[Hg]S
2026-01-26Heart rate60/minS
2026-01-26Respiratory rate14/minS
2026-01-26Body temperature36.7CelS
2026-01-26Oxygen saturation in Arterial blood by Pulse oximetry98%S
2026-03-16Body height178cmS
2026-03-16Body weight78kgS
2026-03-16Body mass index (BMI) [Ratio]24.6kg/m2S
2026-03-16Systolic blood pressure124mm[Hg]S
2026-03-16Diastolic blood pressure76mm[Hg]S
2026-03-16Heart rate58/minS
2026-03-16Respiratory rate14/minS
2026-03-16Body temperature36.6CelS
2026-03-16Oxygen saturation in Arterial blood by Pulse oximetry98%S
2026-05-11Body height178cmS
2026-05-11Body weight77.4kgS
2026-05-11Body mass index (BMI) [Ratio]24.4kg/m2S
2026-05-11Systolic blood pressure122mm[Hg]S
2026-05-11Diastolic blood pressure74mm[Hg]S
2026-05-11Heart rate58/minS
2026-05-11Respiratory rate14/minS
2026-05-11Body temperature36.6CelS
2026-05-11Oxygen saturation in Arterial blood by Pulse oximetry98%S
2026-09-28Body height178cmS
2026-09-28Body weight77kgS
2026-09-28Body mass index (BMI) [Ratio]24.3kg/m2S
2026-09-28Systolic blood pressure124mm[Hg]S
2026-09-28Diastolic blood pressure74mm[Hg]S
2026-09-28Heart rate60/minS
2026-09-28Respiratory rate14/minS
2026-09-28Body temperature36.6CelS
2026-09-28Oxygen saturation in Arterial blood by Pulse oximetry98%S
2026-04-13Body height178cmS
2026-04-13Body weight77.9kgS
2026-04-13Body mass index (BMI) [Ratio]24.6kg/m2S
2026-04-13Systolic blood pressure146mm[Hg]S
2026-04-13Diastolic blood pressure86mm[Hg]S
2026-04-13Heart rate74/minS
2026-04-13Respiratory rate16/minS
2026-04-13Body temperature36.7CelS
2026-04-13Oxygen saturation in Arterial blood by Pulse oximetry98%S
2026-10-19Body height178cmS
2026-10-19Body weight77.2kgS
2026-10-19Body mass index (BMI) [Ratio]24.4kg/m2S
2026-10-19Systolic blood pressure126mm[Hg]S
2026-10-19Diastolic blood pressure76mm[Hg]S
2026-10-19Heart rate60/minS
2026-10-19Respiratory rate14/minS
2026-10-19Body temperature36.6CelS
2026-10-19Oxygen saturation in Arterial blood by Pulse oximetry98%S

Encounters

DatePurposeStatusProvenance
2026-01-12Primary care visit to establish care after myocardial infarction and plan a return to full-time workfinishedS
2026-01-26Two-week blood pressure and kidney check, echocardiogram, and cardiology consultationfinishedS
2026-03-16Lipid review nine weeks after adding ezetimibefinishedS
2026-05-11Seven-month coronary disease review after return to full-time workfinishedS
2026-09-28One-year review after myocardial infarction: end of dual antiplatelet therapyfinishedS
2026-04-13Same-day sick visit for a nosebleed on dual antiplatelet therapyfinishedS
2026-10-19Initial annual wellness visitfinishedS

Plan of Treatment

InterventionStatusGuidelineProvenance
Dual antiplatelet therapy with aspirin 81 mg and ticagrelor 90 mg twice daily for twelve months after the infarction, then aspirin alonecompletedGL-ACS-2025, GL-CMID-2026S
High-intensity atorvastatin with ezetimibe added for LDL cholesterol above 55 mg/dL; recheck lipids 4 to 12 weeks after the change, then every 3 to 12 monthscompletedGL-CCD-2023, GL-CMID-2026S
Metoprolol succinate and lisinopril for blood pressure below 130/80; basic metabolic panel 1 to 2 weeks after an ACE inhibitor change, then every 6 months; reassess the beta-blocker at one yearcompletedGL-CCD-2023, GL-CMID-2026S
Cardiology consultation to establish local cardiology care, reassess left ventricular function, and advise on return to full-time work and on the duration of antiplatelet and beta-blocker therapycompletedGL-ACS-2025, GL-CCD-2023S
After cardiac rehabilitation, a home maintenance program of brisk walking and golf, a Mediterranean-style diet, staying tobacco free, PHQ-2 depression screening at visits, and a written chest-pain plan with sublingual nitroglycerincompletedGL-CCD-2023, GL-CMID-2026S
Yearly influenza vaccine, pneumococcal vaccine, RSV vaccine, and current COVID-19 vaccinecompletedGL-CCD-2023, GL-CMID-2026S

Goals

GoalTargetStatusOutcomeProvenance
Lower LDL cholesterol below 55 mg/dL by the lipid recheck in about two months2026-03-16completedLDL cholesterol 50 mg/dL on atorvastatin and ezetimibeS
Keep blood pressure below 130/80 mmHg2026-03-16completedBlood pressure 124/76 mmHg on lisinopril 10 mg and metoprololS
Return to full-time work and travel by the seven-month review2026-05-11completedFull-time work since late January; travelling againS
Keep at least 150 minutes a week of moderate exercise after cardiac rehabilitation2026-05-11completedBrisk walking most days and golf twice a weekS
Complete twelve months of dual antiplatelet therapy without major bleeding2026-09-28completedTicagrelor stopped at one year; one minor anterior nosebleed onlyS

Functional Status

Mental Status